Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

AIPPI: Personalised medicine tests the limits in patent law
Asia
AIPPI: Personalised medicine tests the limits in patent law
At AIPPI’s World Congress 2025, a panel explored how personalised medicine is pushing patent law into new territory, and why harmonisation remains a distant goal.   18 September 2025
To disclose or not: Pharma patents face new AI reality
Asia
To disclose or not: Pharma patents face new AI reality
From drug discovery to post-market surveillance, AI is rewriting the rules in pharma—and the patent system is struggling to keep up. At AIPPI’s World Congress 2025, Marisa Woutersen hears experts debate AI disclosure, inventive step, and inventorship.   16 September 2025
Trade secrets go global: How brand owners face a high-stakes battlefront
Asia
Trade secrets go global: How brand owners face a high-stakes battlefront
How can companies stay ahead in trade secret protection, from adapting to new legislation and emerging case law to managing cross-border risks? Marisa Woutersen reports from the AIPPI World Congress 2025.   15 September 2025
Americas
Former pharma GC brings in-house perspective to McGuireWoods
After four years as associate general counsel at a pharmaceutical company, the partner returns to private practice with experience across patents, trademarks, copyright and trade secret litigation.   12 September 2025
Careers
Buchalter brings in new partner to head up medtech
The firm’s medtech practice will be led by a partner with experience in digital health, medical devices, and emerging technologies, with particular expertise in advising startups.   10 September 2025
Americas
Trump’s march-in rights threat: Why pharma is rethinking university deals
Federal oversight, funding cuts, and patent uncertainties are forcing universities, startups, and pharma companies to reassess partnership models, finds Marisa Woutersen.   9 September 2025
Americas
GSK escalates mRNA COVID-19 vaccine dispute
The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech.   5 September 2025
Europe
The flaw that landed Sanofi a win in the rare disease space
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen.   4 September 2025
Americas
Roche resolves cancer test dispute with Stanford affiliated startup
The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims.   4 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
The company’s decision to sue US customs may result in a “roadmap” to sidestep ITC orders—and patent litigators are watching, finds Marisa Woutersen.   3 September 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.